These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23602539)

  • 1. A measles eradication goal is upon us; can rubella and congenital rubella syndrome be far behind?
    Sniadack DH; Orenstein WA
    Vaccine; 2013 May; 31(24):2659-60. PubMed ID: 23602539
    [No Abstract]   [Full Text] [Related]  

  • 2. Research priorities for global measles and rubella control and eradication.
    Goodson JL; Chu SY; Rota PA; Moss WJ; Featherstone DA; Vijayaraghavan M; Thompson KM; Martin R; Reef S; Strebel PM
    Vaccine; 2012 Jul; 30(32):4709-16. PubMed ID: 22549089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The end of measles and congenital rubella: an achievable dream?
    Adamo G; Sturabotti G; D'Andrea E; Baccolini V; Romano F; Iannazzo S; Marzuillo C; Villari P
    Ann Ig; 2017; 29(1):1-26. PubMed ID: 28067934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting of the International Task Force for Disease Eradication, November 2015.
    Wkly Epidemiol Rec; 2016 Feb; 91(6):61-71. PubMed ID: 26875204
    [No Abstract]   [Full Text] [Related]  

  • 5. Roadmap to elimination standard measles and rubella surveillance.
    Wkly Epidemiol Rec; 2017 Mar; 92(9-10):97-105. PubMed ID: 28262010
    [No Abstract]   [Full Text] [Related]  

  • 6. Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2014.
    Wkly Epidemiol Rec; 2015 Sep; 90(39):510-6. PubMed ID: 26410894
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress in rubella and congenital rubella syndrome control and elimination – worldwide, 2000–2016.
    Wkly Epidemiol Rec; 2017 Nov; 92(46):707-15. PubMed ID: 29148274
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algoritmo diagnóstico para la confirmación de casos de sarampión y rubéola en México.
    Román-Pedroza JF; Cruz-Ramírez E; Landín-Martínez KE; Salas-García M; López-Ortiz E; Ramírez-González JE; López-Martínez I; Díaz-Quiñonez JA
    Gac Med Mex; 2019; 155(5):532-536. PubMed ID: 31695226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles and rubella eradication.
    Hinman AR
    Vaccine; 2018 Jan; 36(1):1-3. PubMed ID: 29183733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plan for the Elimination of Measles and Rubella in Spain].
    Limia Sánchez A
    Rev Esp Salud Publica; 2015; 89(4):393-6. PubMed ID: 26580794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.
    Grant GB; Reef SE; Dabbagh A; Gacic-Dobo M; Strebel PM
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(37):1052-5. PubMed ID: 26401958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards eliminating rubella and congenital rubella syndrome in the western hemisphere, 2003-2008.
    Wkly Epidemiol Rec; 2008 Oct; 83(44):395-400. PubMed ID: 18975450
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.
    Thompson KM
    Risk Anal; 2017 Jun; 37(6):1041-1051. PubMed ID: 28471528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.